Bolton Securities’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
Bolton Securities's RYTM Position: Q3 2026 in Review
Bolton Securities held its Rhythm Pharmaceuticals (RYTM) position steady in Q3 2026 at 300 shares worth $28.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1521.
Bolton Securities first reported a position in RYTM in Q1 2025 and has held it in 7 quarters since. The position peaked at $33.3K in Q2 2026. 328 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- Bolton Securities held 300 shares of Rhythm Pharmaceuticals worth $28.6K as of Q3 2026.
- Bolton Securities left its Rhythm Pharmaceuticals share count unchanged in Q3 2026.
- Rhythm Pharmaceuticals made up ﹤0.01% of Bolton Securities's portfolio in Q3 2026, its #1521 holding.
- Bolton Securities first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- Bolton Securities's Rhythm Pharmaceuticals position peaked at $33.3K in Q2 2026.
- 328 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on Bolton Securities's 13F filing for Q3 2026, filed 12 Nov 2026.